PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3301/1/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Vifor
An anonymous, contactable complainant alleged the ivironheart.co.uk website (ref UK-NP-1900153, Sept 2019) was disguised promotion of Vifor’s Ferinject (ferric carboxymaltose) and that it was not…
Clauses: NONE
🔒 Subscribers only
AUTH/3340/4/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare breached Clause 4.1 and 9.1 after a promotional website PDF carried out-of-date pres
A UK health professional complained that a PDF downloaded from ViiV Exchange (a promotional website for health professionals) contained out-of-date prescribing information.The PDF covered four prod…
Clauses: NONE
🔒 Subscribers only
AUTH/3362/6/20
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche voluntarily admitted that a promotional email for Tecentriq (atezolizumab) was inadvertently sent by a third-party agency to members of the public.The email was intended for UK oncologists an…
Clauses: NONE
🔒 Subscribers only
AUTH/3331/4/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A concerned UK health professional complained about a GlaxoSmithKline (GSK) advertisement for Relvar Ellipta in the December 2019 edition of Pulse magazine (viewed online).The complainant alleged t…
Clauses: NONE
🔒 Subscribers only
AUTH/3341/5/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
During a separate complaint (Case AUTH/3328/4/20), GlaxoSmithKline UK Limited (GSK) reviewed 11 Avamys banner ads approved for UK use in 2019/20 and found two additional online banner advertisement…
🔒 Subscribers only
AUTH/3321/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
A Menarini breached Clause 12.1 after PDF supplement lacked clear upfront company involvement (Ranex
A UK health professional complained that a supplement hosted on the Guidelines in Practice website and produced by A Menarini was disguised promotion for Ranexa (ranolazine).The item was titled: �…
Clauses: NONE
🔒 Subscribers only
AUTH/3323/3/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva breached Clause 4.1 after DuoResp Spiromax prescribing information was hard to read in sponsore
A concerned UK health professional complained about the legibility of DuoResp Spiromax (budesonide/formoterol) prescribing information shown in a recorded webinar commissioned by Teva UK Limited (r…
Clauses: 4.1
🔒 Subscribers only
AUTH/3319/3/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
A UK health professional complained about promotional material for Symbicort (budesonide/formoterol) created by AstraZeneca UK Ltd and hosted on the Guidelines in Practice website.The complaint foc…
Clauses: NONE
🔒 Subscribers only
AUTH/3322/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
A UK health professional complained about two videos hosted on the ‘Guidelines in Practice’ website: ‘Secondary event prevention and risk stratification in patients with symptomatic periphera…
Clauses: NONE
🔒 Subscribers only
AUTH/3317/3/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim breached Clause 4.3 after omitting generic names next to Spiolto/Spiriva brand
An anonymous complainant (a concerned UK health professional) raised concerns about a Guidelines in Practice webpage hosting a Boehringer Ingelheim promotional video: “Respimat Soft Mist reusable…
Clauses: 4.3
🔒 Subscribers only
AUTH/3310/2/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Indivior
An anonymous, non-contactable ex-employee complained about an online article in Pharmaceutical Market Europe (PME)/PMLiVE (Dec 2019) titled “As the opioid crisis grabs the headlines, the search f…
Clauses: NONE
🔒 Subscribers only
AUTH/3328/4/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK breached ABPI Code after Avamys digital banner’s generic name was not readily readable (AUTH/332
An anonymous individual (a concerned UK health professional) complained about a dynamic digital banner advertisement for Avamys (fluticasone furoate nasal spray) on Pulse (pulsetoday.co.uk).The com…
Clauses: 4.3
🔒 Subscribers only
AUTH/3367/7/20
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
GSK Duac
A UK health professional complained they could not access prescribing information (PI) for Duac 5% (benzoyl peroxide, clindamycin phosphate) from an online advertisement on Pulse Today (ref PM-GB-C…
Clauses: NONE
🔒 Subscribers only
AUTH/3293/1/20
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim breached ABPI Code over Pradaxa 110mg website claim implying use in “any patien
An anonymous health professional complained about promotion of Pradaxa (dabigatran) by Boehringer Ingelheim Limited.The complaint focused on the claim: “recommended for use in any patient at incr…
Clauses: 4.1,4.3
🔒 Subscribers only
AUTH/3308/2/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK respiratory webinar pages
A health professional complained about two webinar registration pages on GSK’s UK HCP events website. The complainant alleged an earlier asthma webinar page previously ruled in breach (AUTH/317…
Clauses: NONE
🔒 Subscribers only
AUTH/3309/2/20
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sintetica
A UK health professional complained about a LinkedIn post made by a senior executive of Sintetica Limited.The post announced that Ampres 20mg/ml solution for injection had been approved for periphe…
Clauses: NONE
🔒 Subscribers only
AUTH/3347/5/20
Social Media & Digital Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Strides Pharma
A member of the public complained that Strides Pharma UK Ltd promoted Strivit D3 (colecalciferol), a prescription only medicine (POM), to the public on LinkedIn.Vitabiotics Ltd posted on LinkedIn a…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/3345/5/20
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Sobi breached ABPI Code over ‘No anaphylaxis or allergic reactions’ claim in Alprolix BMJ hosted adv
A UK health professional complained about a Sobi advertisement for Alprolix (eftrenonacog alfa) on a BMJ-hosted webpage.The section was presented under a tolerability heading referencing clinical s…
Clauses: 3.2,9.1
🔒 Subscribers only
AUTH/3339/4/20
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Accord breached ABPI Code after LinkedIn post described POMs as “vital COVID-19 medicines” (AUTH/333
An anonymous, contactable employee complained about an Accord-UK Ltd corporate LinkedIn post.The post said that, due to growing demand for “vital COVID-19 medicines”, including cisatracurium, m…
Clauses: 2,4.3
🔒 Subscribers only
AUTH/3320/3/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda breached ABPI Code over unclear differentiation between Prostap SR DCS and Prostap 3 DCS indi
A UK health professional complained about Takeda promotional material for Prostap (leuprorelin acetate) hosted on the Guidelines in Practice website.The materials included a “Formulary Decision G…
Clauses: NONE
🔒 Subscribers only
AUTH/3303/1/20
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Vifor Ferinject website
An anonymous, contactable complainant challenged content on Vifor Pharma UK’s Ferinject (ferric carboxymaltose) website (ferinject.co.uk; refs incl. UK-FCM-1900320, September 2019).The open-acces…
Clauses: NONE
🔒 Subscribers only
AUTH/3332/4/20
HCP Hospitality & Meetings Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Sobi
An anonymous, non-contactable complainant (on behalf of a hospital haematology team) alleged an unsolicited email from a Sobi medical science liaison (MSL) to an NHS email address was inappropriate…
Clauses: NONE
🔒 Subscribers only
AUTH/3190/4/20
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda
An anonymous contactable group (GPs, NHS leaders, pharmacists, NHS patients and staff from a named third-party therapy review provider) complained about sponsored therapy review services delivered …
Clauses: NONE
🔒 Subscribers only
AUTH/3386/9/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous health professional complained about GSK’s public website page: https://lowcarboninhalers.co.uk/public (ref NP-GB-RS-WCNT-190008, November 2019).The complainant alleged the page enco…
Clauses: NONE
← Prev 17 18 19 20 21 22 23 Next → Page 20 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews